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Summary Short-term cultures from 20 pancreatic tumours, three endocrine and 17 exocrine, were cyto-
genetically analysed. All three endocrine tumours had a normal chromosome complement. Clonal chromosome
aberrations were detected in 13 of the 17 exocrine tumours: simple karyotypic changes were found in five
carcinomas and numerous numerical and/or structural changes in eight. When the present findings and those
previously reported by our group were viewed in conjunction, the most common numerical imbalances among
the 22 karyotypically abnormal pancreatic carcinomas thus available for evaluation turned out to be, in order
of falling frequency, - 18, - Y, +20, +7, + 11 and - 12. Imbalances brought about by structural changes
most frequently affected chromosomes I (losses in lp but especially gains of lq), 8 (in particular 8q gains but
also 8p losses), and 17 (mostly 17q gain but also loss of 17p). Chromosomal bands lp32, 1q1O, 6q21, 7p22,
8p2l, 8ql 1, 14pl 1, l5q10-1 1, and 17qll were the most common breakpoint sites affected by the structural
rearrangements. Abnormal karyotypes were detected more frequently in poorly differentiated and anaplastic
carcinomas than in moderately and well differentiated tumours.
Pancreatic carcinoma accounts for about 10% of malignan-
cies of the digestive organs and the outcome is fatal in more
than 95% of the cases. Thus, cancer of the pancreas, once a
rare disease, has gained in quantitative importance and today
represents one of the great challenges in clinical oncology
(Cubilla & Fitzgerald, 1984; Kloppel & Heitz, 1984; Andren-
Sandberg et al., 1991).
Investigations of the molecular genetic alterations in pan-
creatic cancer cells have focused on the detection of muta-
tions of the RAS family of oncogenes (Barbacid, 1987;
Griunewald et al., 1989; Mariyama et al., 1989; Shibata et al.,
1990) and abnormalities of the TP53 tumour suppressor gene
(Barton et al., 1991; Neuman et al., 1991). Another level of
genomic organisation that lends itself to direct examination is
the karyotype; characteristics karyotypic patterns and even
specific chromosome abnormalities are being detected in ever
more diagnostic categories of solid tumours (Heim & Mitel-
man, 1992). So far, very few pancreatic tumours have been
successfully analysed by cytogenetic techniques (van der Riet-
Fox et al., 1979; Bullerdiek et al., 1985; Casalone et al., 1987;
Teyssier, 1987; Johansson et al., 1992). The late detection of
pancreatic cancer, when the tumours cannot be extirpated,
and the difficulties in initiating short-term cultures and in
obtaining chromosome preparations of good quality in those
cases in which surgery is performed are among the main
reasons for the paucity of cytogenetic information.
In this report we present the cytogenetic findings in short-
term cultures from 20 pancreatic tumours. We added to this
information another 17 tumours of the pancreas previously
reported by us (Johansson et al., 1992), and discuss the
pathogenetic implications of the karyotypic features on the
basis of the total material of 37 tumours.
Materials and methods
Tumour material and histopathology
Tissue samples from 20 primary tumours of the pancreas
were obtained at the time of surgery between November 1990
and May 1992. The pathologic examination of the tumours
was undertaken without prior knowledge of their karyotypic
characteristics. Clinical and histopathological features are
summarised in Table I.
Cytogenetic methods
To rinse the tumour tissue from fat, clotted blood, and
necrotic tissue, the samples were washed in sterile petri dishes
in a washing medium consisting of RPMI-1640 with the
additives penicillin (200 IU ml-'), streptomycin (0.4 mg
ml-'), and amphotericin B (2.51g ml-'). The tissue was then
transferred to another petri dish, cut with scissors as finely as
possible, and treated with 0.8% collagenase type II (Worth-
ington) in a humidified incubator in 5% CO2 in air at 37°C
until a high proportion of small aggregates resulted, usually
after -3 h. The suspension was spun down at 200 g for
10 min, resuspended in washing medium, and spun down
again. The sediment was resuspended in growth medium and
transferred to 25 cm2 plastic flasks (Primaria, Falcon). The
growth medium was RPMI-1640 or Dulbecco's MEM/F12
(1:1), both with HEPES buffer and supplemented with 5%
foetal bovine serum, glutamine (0.23 mg m1-), penicillin
(100 IU ml'), streptomycin (0.2 mg ml-1'), amphotericin B
(2.5 jgml-'), epidermal growth factor (1Ongml1'), hydro-
cortisone (0.5 ytg ml-'), cholera toxin (50 ytg ml-'), dibutyl
cyclic AMP (1OnM), and 1% ITS+ (Flow), giving the fol-
lowing final concentrations: insulin (6.25 .Lg ml1'), transferrin
(6.25 lg ml-'), selenious acid (6.25 ng ml-'), bovine serum
albumin (1.25 mg ml-'), and linoleic acid (5.35 jg ml-').
When numerous cell clumps had attached - usually after 24 h
- the medium, which then always contained floating cells and
cell clusters, was transferred to additional flasks, directly or
after centrifugation, in an attempt to establish more primary
cultures. The growth medium was changed every 2 days.
After 2-5 days, Colcemid was added for 3-6 h (0.06 tLg
ml-') or overnight (0.02 jtg ml-'), the cultures were harvest-
ed, and chromosome preparations were made as described by
Pandis et al. (1992a). The chromosome preparations were
first incubated overnight at 60°C in air and then for 3 h in
2 x sodium saline citrate at 60°C. After at least another 2 h
drying at room temperature, the preparations were banded
with Wright's stain.
In the subsequent chromosome analysis, the clonality cri-
teria and description of tumour karyotypes followed the
recommendations of the ISCN (1991).
Results
Clonal karyotypic aberrations were detected in 13 tumours
(Table II), whereas seven had a normal karyotype. Abnormal
but simple karyotypes were found in five tumours: two had a
single numerical change (+ 17 in case 2 and
- Y in case 6),
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Table I Clinical and histopathologic features
Casel Age (yrs)/ Sizec
lab no. sex Diagnosis Grade" Siteb (cm) Staged
1/2901-90 55/F Endocrine tumour e Cap 8 IV
2/3266-90 49/M Adenoca ductal M Cap 3 III
3/409-9,1 60/F Adenoca papillary W - 7 IV
4/451-91 49/F Adenoca M Corp - IV
5/725-91 72/F Endocrine tumour - Caud S IV
6/892-91 74/M Adenoca papillary W Pap 5 IV
7/902-91 76/M Adenoca papillary W Pap 1.5 I
8/1574-91 48/M Cancer' P Cap - IV
9/1941-91 46/F Adenoca M Cap - IV
10/1944-91 69/M Cystadenoca mucinous W Cap 15 II
11/2087-91 65/F Carcinoma ductal A Cap 5 III
12/2271-91 55/M Adenoca papillary W Pap 2 II
13/2402-91 68/M Adenoca M Corp
14/2873-91 60/M Carcinoma ductal A _ 1.5 IV
15/3535-91 54/M Insulinoma - Caud 1.7 I
16/3581-91 70/F Adenoca M Cap 3 III
17/96-92 72/F Adenoca papillary M
18/205-92 61/M Adenoca M - 10 IV
19/257-92 65/M Adenoca M - - IV
20/992-92 77/M Adenoca P Pap 1.5 III
aAdenoca: adenocarcinoma; M: moderately differentiated; W: well differentiated; P:
poorly differentiated; A: anaplastic. bCap: caput pancreatis; Corp: corpus pancreatis;
Caud: cauda pancreatis; Pap: papilla Vateri. cLargest diameter of the tumour.
dAccording to UICC (1987). eDash indicates that no information was available.
fDiagnosis based on cytologic analysis only.
Table II Clonal chromosome aberrations in 13 pancreatic carcinomas
Case
No. Karyotypesa
2 47,XY, + 17[2]/46,XY[23]
6 45,X, - Y[5]/46,XY[24]
8 61-68,XXY, + 1, + 2, +3,-4,add(4) (p15), + 6, + 7,der(7)t(7;15)
(p22;ql l)x2,+der(8)t(8;?;8)(p21;?;q22),add(9)(p13),-11,
- 12,i(12)(qlO),- 13,-14,-i5,-15,-15,+ 16,- 17,-18,inv(18)
(qilq21)x2, - l9,der(20)t(?5;20)(q21;p13),-21, + 22,der(22)
t(8;22)(ql l;pll)x2, +2- 6mar[10]/46,XY[l 1]
10 46,XY,del(10)(q22q24)[11]/46,XY[4]
11 87-93,XX,-X,-X,- 1,+2,-3,-4,+5,+ i(5)(plO),-6,+7,-9,- 10,
- 10,- 12,- 13,add(14)(pll),i(l5)(qlO),+ 16,+ 17,- 18,+ 19,+20,
+20,- 21, +22[16]/160-200,idemx2[7]/46,XX[5]
12 40,X, - Y, - 3,t(6;18)(q21;q21),-der(8;1 1)(q0O;qlO),inv(9)
(p1 lp24), - 11,- 15,- 16,- 17,- 18,der(19)t(6;19)(q21;p13),
+der(22)t(3;22)(q l;p11)[18]/69-87,idemx2[9]/47,XY, +7[4]/
46,XY[3]
13 42-45,Y,add(X)(p22), -3,i(5)(plO),add(7)(p22),- 8,der(9)
t(9;12)(p13;q11),del(10)(pl 1),- 12,add(15)(pl 1),add(16)(q?),
der(l7)t(1;17)(q21;p13),add(17)(ql 1),- 18,-20,- 21, +der(?)
t(?;8)(?;q13),+?der(?)t(?;8)(?;q22), + 1-2mar[9]/80,idemx2
[11]/46,XY[6]
14 67-77,XXY, +Y,add(1)(p36), +der(1;16)(qlO;plO), +2,del(2)
(q33)x2,-3,-4,-5,-6,-7,-8,-9,- 10,- 10,+ 11,- 12,- 13,der(14)
t(8;14)(q1l;pl l)x2,+ 17,der(17)t(?6;17)(q21;q24)x2,- 18,
der(l9)add(19)(pl3)hsr(?), -20,- 21,+der(22)t(14;22;?)
(q13;q13;?),der(?)t(?;7)(?;ql 1),+der(?)t(?;7)t(3;7)
(p21;q36),+r,+5-13mar[34]/46,XY[21
16 84-86,XXXX, - 1,del(3)(p13p24),add(4)(p12-16),dic(5;21)
(plS;pl1), -6,-9,-12,- 13,der(13;15)(qlO;qlO),add(14)(pl1),
- 15,- 18,add(20)(q13),+2-3mar[7]/l50-160,idemx2[7]/46,XX[21]
17 47,XX, +i(l)(q10)[7]/46,XX[12]
18 43-45,XY, -1,der(1)ins(1;?)(p34;?)t(1;1)(p36;p13),add(4)
(q35),del(7)(q22q32),-8, +der(11)del(11)(pl 1)del(11)(q23),
i(l7)(qlO), - 18,- 22[3]/43-45,idem, + 17[3]/43-45,idem,+mar[4]/
47,XY, +7[9]/46,XY[4]
19 69-79,XXY,+Y,- 1,+2,-6,+9,+ 12,+ 13[15]/73-74,XXY,+Y,i(l)
(qlO),+2,-6,+8,+9,- 10,+ 11,+ 12,+ 13,+14,+ 19[13]/78-81,XXY,
+Y,+2,+5,-6,+der(7)t(1;7)(ql2;qll),+11,+ 12,+13,+14,-16,
+20[15]/150,XY?,inc[5]/46,XY[6]
20 46,XY,t(1;19)(p31;q13),t(8;21)(q21;q22)[2]/45,X,-Y[5]/
46,XY[10]
aNumbers in square brackets denote number of mitoses in each clone.
two had a single structural change (del(l0)(q22q24) in case 10 terised by numerous numerical and structural aberrations
and +i(l)(qlO) in case 17), and the fifth (case 20) had two (Figure 1). In two of these tumours (cases 12 and 18) an
balanced translocations in one clone and -Y in another. In additional abnormal clone, with +7 as the sole change, was
the remaining eight cases, the tumour karyotype was charac- found. The modal chromosome number was neardiploid in1108 G. BARDI et al.
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eight tumours (hyperdiploid in two, pseudodiploid in two
and hypodiploid in four), neartriploid in three, and neartetra-
ploid in two tumours.
Evidence of clonal evolution, i.e., cytogenetically related
clones, including duplications and triplications of the mother
clone, was found in six tumours (cases 11, 12, 13, 16, 18 and
19). In these polyploid aberrant clones, rings, quadruplica-
tions, and other complex chromosome rearrangements were
sometimes observed but could, due to the complexity and the
high chromosome number in these cells, not always be identi-
fied.
The most common numerical changes were (compared
with the nearest euploid level) losses of chromosomes 18
(seven cases), 12 (five cases) and 1, 3, 6, 8, 13 and 21 (four
cases each). The chromosome bands most frequently involved
in structural rearrangements were 1q1O, 6q2l, 14pl and
I5qI0-I1 (three cases each) and lp36, SplO, 7p22, 7ql1,
8qll, 8q22, 9pl3, 18q21, l9pl3 and 22pll (two cases each)
(Figure 2).
Discussion
Most of the tumours (17 of 20) of the present series were
carcinomas of the exocrine pancreas (Table I), of which 13
(76%) had clonal chromosome aberrations. There seemed to
be no cytogenetic difference between the four tumours of the
papilla Vateri and the other carcinomas. On the other hand,
all three endocrine tumours, two of which were malignant
(cases 1 and 5), had normal karyotypes. The numbers are
small, but one cannot discount the possiblity that the differ-
ent findings in the two sets of pancreatic tumours reflect
systematic biological differences between neoplasms of the
exocrine and endocrine portions of the gland. Of relevance in
this context is also that the culture technique we use is more
suited to the nutritional necessities and the growth chracteris-
tics of adenocarcinomas, the dominant exocrine pancreatic
tumours, than to those of the rare, slowing growing, and
biologically highly complex endocrine tumours (Kloppel &
Heitz, 1984; Ch'ng et al., 1986). The fact that no previous
report has described the cytogenetic investigation of endo-
crine pancreatic tumours (Mitelman, 1991) adds to the diffi-
culty when it comes to interpreting the importance of the
normal karyotypes.
To obtain a more complete picture of the chromosome
aberrations in pancreatic adenocarcinomas, we have com-
bined the findings of the present series - 13 tumours with
clonal abnormalities - with those of a previous report by us,
which included nine pancreatic cancers with clonal chromo-
some aberrations (Johansson et al., 1992). Our total material
therefore consists of 22 karyotypically abnormal pancreatic
carcinomas. This represents a significant proportion of the
total available data base; we know of only five cytogenetic-
ally abnormal cancers of the pancreas reported by other
investigators (van der Riet-Fox et al., 1979; Bullerdiek et al.,
1985; Casalone et al., 1987; Teyssier, 1987).
The most frequent numerical changes in our combined
series were - 18 (found in 11 cases, 50%), -Y (found in
seven of the 15 male patients with abnormal karyotype,
47%), +20 (eight cases, 36%), +7, +11, and - 12 (seven
cases each, 32%), and -1, +2, -6, -8, -15, +19 and
-21 (five cases each, 23%). Gain of chromosomes 20 and 7
and loss of 18 and Y are among the most common numerical
changes also in colorectal adenocarcinomas (Muleris et al.,
1990; Bardi et al., 1993), underscoring the karyotypic simil-
arities among the various gastrointestinal cancers. Genetic
similarities are evident also at the molecular level, with loss
of heterozygosity on Ip, 5q, 1 lq, 17p and 18q being detected
not only in colorectal but also in pancreatic adenocarcinomas
(Neuman et al., 1991; Ding et al., 1992; Hohne et al., 1992).
Structural aberrations were present in 17 of the 22 pan-
creatic cancers with karyotypic abnormalities. Chromosomes
1, 3, 6, 7, 8, 15 and 17 were involved in six or more cases.
The most common breakpoint sites were lp32, 1q1O, 6q21,
7p22, 8p2l, 8ql1, 14pll, 15qlO-l1, and 17ql1 (at least three
times, Figure 2). Bands 1q1O, 8ql1, and 17ql 1 are also
frequently rearranged in colorectal carcinomas (Muleris et
al., 1990; Bardi et al., 1993), indicating that genes involved in
the initiation or progression of both colorectal and pan-
creatic malignancies may be located here. The most common
karyotypic imbalances (Figure 3) brought about by the struc-
tural changes were of chromosomes 1 (both partial and
complete losses of lp and, especially, gains of lq), 8 (gains of
8q and loss of 8p), and 17 (gain of 17q and loss of 17p).
There evidently is no good correspondence between complete
and partial polysomies or between complete and partial
monosomies.
Cases with simple structural chromosomal rearrangements
may be particularly informative about the early genetic
changes of cancers, since it can be argued that they must
represent primary abnormalities (Mitelman, 1984). This argu-
ment can be exemplified by case 17, in which a super-
numerary i(lq) was the sole aberration and, hence, must be
accepted as a likely candidate for an early and pathogene-
tically important change. This view is supported by the fact
that gain of lq material was the most frequent imbalance in
our series (Figure 3). Isochromosome lq has, as the only
abnormality, otherwise been described in an endometrial car-
cinoma (Fujita et al., 1985), in an ovarian tumour (Pejovic et
al., 1993), and in cancers of the breast (Pandis et al., 1992b).
As one of several changes, on the other hand, +i(lq) is a
frequent finding (Mitelman, 1991).
The diagnosis of case 10, in which a solitary deletion ofthe
long arm of chromosome 10 was found, was mucinous cyst-
adenocarcinoma, a less malignant cancer than ductal adeno-
carcinoma (Compagno & Oertel, 1979; Hodgkinson et al.,
1978). This patient also had nesidioblastosis, a supposedly
paraneoplastic disorder of endocrine pancreatic cells that
proliferate reactively in close contact with and complicating
disease processes of the exocrine pancreas, e.g., pancreatic
carcinomas (Eusebi et al., 1981; Kloppel & Heintz, 1984;
Permert et al., 1991). Rearrangements of lOq have previously
been found in, e.g., thyroid tumours - the only endocrine
neoplasms that have been cytogenetically examined in any
numbers - and it has been suggested that they characterize
nonmedullary carcinomas, especially those whose growth pat-
tern is papillary (Jenkins et al., 1990).
Data are insufficient for any extensive correlation of cyto-
genetic and pathologic parameters. We nevertheless note that
an abnormal karyotype was detected in three of the five well
differentiated carcinomas, in nine of the 18 moderately differ-
entiated carcinomas, in seven of the eight poorly differ-
entiated carcinomas, and in both cancers that were classified
as anaplastic. A rough parallelism therefore seems to exist
between the degree of anaplasia and the likelihood of finding
karyotypic abnormalities in cancers of the pancreas.
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